Jinpeng Liu Selected Research

Jinpeng Liu Research Topics

Disease

15	Neoplasms (Cancer) 01/2022 - 01/2017
5	Colorectal Neoplasms (Colorectal Cancer) 06/2022 - 01/2018
4	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2019
4	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2018
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2020
2	Adenocarcinoma of Lung 11/2021 - 09/2020
2	Melanoma (Melanoma, Malignant) 10/2020 - 01/2018
2	Carcinogenesis 12/2019 - 12/2019
2	Solitary Kidney 01/2019 - 01/2018
2	Acute Kidney Injury (Acute Renal Failure) 01/2019 - 05/2018
1	Adenoma (Adenomas) 06/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Disease Progression 01/2021
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Breast Neoplasms (Breast Cancer) 12/2020
1	Leukemia 10/2020
1	Hyperplasia 10/2020
1	Body Weight (Weight, Body) 10/2020
1	COVID-19 10/2020
1	Metaplasia 10/2020
1	Dysbiosis 01/2020
1	Obesity 01/2020
1	Inflammation (Inflammations) 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Lymphoma (Lymphomas) 01/2018

Drug/Important Bio-Agent (IBA)

3	Fatty Acid Synthases (Fatty Acid Synthase)IBA 06/2022 - 05/2018
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
3	ErbB Receptors (EGF Receptor)IBA 11/2021 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2022 - 10/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2019
2	Tyrosine Kinase InhibitorsIBA 11/2021 - 01/2021
2	Hormones (Hormone)IBA 12/2020 - 01/2020
2	CreatinineIBA 10/2020 - 10/2020
2	CateninsIBA 12/2019 - 01/2018
2	TVB-3664IBA 01/2019 - 05/2018
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2019 - 05/2018
2	Phosphotransferases (Kinase)IBA 01/2019 - 01/2018
1	villinIBA 06/2022
1	Decitabine FDA Link 01/2022
1	MethyltransferasesIBA 01/2022
1	Androgen Receptors (Androgen Receptor)IBA 01/2022
1	enzalutamideIBA 01/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	PlatinumIBA 01/2021
1	P-2 (P 2)IBA 01/2021
1	HM781-36BIBA 01/2021
1	Lapatinib (GW572016)FDA Link 01/2021
1	BerberineIBA 01/2021
1	FructoseIBA 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	Long Noncoding RNAIBA 01/2021
1	nilotinib FDA Link 10/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2020
1	Retinaldehyde (Retinal)IBA 10/2020
1	Anaplastic Lymphoma KinaseIBA 09/2020
1	AntibodiesIBA 01/2020
1	B7-H1 AntigenIBA 01/2020
1	NeurotensinIBA 01/2020
1	DefensinsIBA 01/2020
1	Biological ProductsIBA 12/2019
1	Phenobarbital (Luminal)FDA Link 12/2019
1	Biomarkers (Surrogate Marker)IBA 12/2019
1	TetraspaninsIBA 12/2019
1	Cyclin D1IBA 12/2019
1	dihydrosphingosine 1-phosphateIBA 01/2019
1	sphingosine kinaseIBA 01/2019
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	SphingolipidsIBA 01/2019
1	SphingosineIBA 01/2019
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 01/2019
1	S100 Calcium-Binding Protein A4IBA 01/2019
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2019
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2019
1	GelatinIBA 01/2019
1	HexokinaseIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 10/2018
1	SphingomyelinsIBA 05/2018
1	Adenine NucleotidesIBA 05/2018
1	EnzymesIBA 05/2018
1	LipidsIBA 05/2018
1	CDw17 antigen (lactosylceramide)IBA 05/2018
1	Phospholipids (Phosphatides)FDA LinkGeneric 05/2018
1	MicroRNAs (MicroRNA)IBA 05/2018
1	Cathepsin LIBA 01/2018
1	Peptide Hydrolases (Proteases)FDA Link 01/2018
1	CarcinogensIBA 01/2018
1	Cathepsin BIBA 01/2018
1	CathepsinsIBA 01/2018
1	Cysteine (L-Cysteine)FDA Link 01/2018
1	MTOR InhibitorsIBA 01/2018

Therapy/Procedure

5	Therapeutics 01/2022 - 01/2020
4	Transplantation 10/2020 - 04/2016
2	Immunotherapy 01/2022 - 10/2020
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2021
2	Precision Medicine 11/2021 - 05/2018
1	Ketogenic Diet 01/2022